Liz Higgins

Liz has over 20 years of experience in the biopharmaceutical industry, most recently working on AAV gene therapy at NysnoBio. Previously she was part of the Tech Ops teams at Voyager Therapeutics and Prevail Therapeutics (a wholly owned subsidiary of Eli Lilly and Company).